Guffon, Nathalie http://orcid.org/0000-0002-3052-2366
Journeau, Pierre
Brassier, Anaïs
Leger, Juliane
Chevallier, Bertrand
Funding for this research was provided by:
Sanofi Genzyme
Article History
Received: 29 November 2018
Revised: 21 January 2019
Accepted: 23 January 2019
First Online: 11 February 2019
Compliance with ethical statements
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: The authors declare that they have no competing interests.
: N. Guffon has received grants to institution and investigator fee for her participation in clinical trials with Chiesi, Sanofi, BioMarin, Shire HGT, and Sobi, and has received honoraria and travel support from Sanofi Genzyme, Shire HGT, and Chiesi to participate in scientific meetings.P. Journeau has received honorarium as advisor from Orthopediatrics and consulting fees from Sanofi Genzyme to participate in scientific meetings.A. Brassier has received honoraria and travel support from Sanofi Genzyme, Shire HGT, BioMarin, and Orphan Europe, to participate in scientific meetings, and investigator fees for her participation in clinical trials with Alexion.J. Léger is currently an investigator in a clinical trial using growth hormone (GH) from Novo-Nordisk, support for travel to international meetings from several GH manufacturers (Ipsen, Merck, Novo Nordisk, Lilly), fees for lectures from Ipsen Pharma and Merck, and consulting fee from Sanofi Genzyme.B. Chevallier has no financial disclosure.